Business news

Digitization to take the Transseptal Access Systems Market to the exponential curve

Transseptal Access Systems

Complexities in Lifestyle along with in increase in population aged 65 and Above to drive the inclination towards Transseptal Access Systems

With rising geriatric population coupled with millennials going foor an increasing intake of tobacco, alcohol, and altering lifestyles, the transseptal access systems market is expected to stand in a good stead in the forecast period. Persistence Market Research has walked through these nitty-gritties in its market study entitled “Transseptal Access Systems Market”.

Categorization of Transseptal Access Systems Market

The global transseptal access systems market, by product, spans transseptal access needles (standard curve (CO) needles and large curve (C1) needles) and transseptal access sheaths (steerable sheaths and fixed sheaths). Application-wise, it’s mitral valve repair atrial fibrillation ablation, and left atrial appendage occlusion. By end-user, it’s ASCs (Ambulatory Surgical Centers) speciality clinics, and hospitals. Out of these, atrial fibrillation ablation rules the roost due to an increasing demand for catheter-based atrial fibrillation ablation. Various governments are also taking up initiatives for supporting and creating awareness herein. For example – the month of September is observed as “Atrial Fibrillation Awareness” month. It is termed as a valuable period regarding creation of benevolence for life-threatening arrhythmia by the Heart Rhythm Society.

Region-wise Analysis

North America holds the largest market share due to the US being subject to healthcare facilities and several healthcare facilities. Coming to Europe, Germany leads from the front due to growing incidences of atrial fibrillation herein. However, the Asia-Pacific is expected to grow at the fastest rate in the transseptal access systems market due to an increasing number of people suffering from rheumatic valvular heart disease. The Indian Journal of Medical Research (IJMR) states that in South Asia, frequency of rheumatic valvular disease is 1.5-2/1000 in every age group, which comes to 2-2.5 Mn patients. Persistence Market Research has tabled these facts with insights in its latest market study entitled “Transseptal Access Systems Market”.

Get To Know More –

The Competitive Stint

Persistence Market Research has profiled the transseptal access systems market as Terumo Corporation, Medtronic PLC, St. Jude Medical (Abbott Laboratories), Boston Scientific, Biosense Webster, Inc., Merit Medical Systems, Inc., Baylis Medical Company Inc., Pressure Products Medical Device Manufacturing LLC, Cook Medical LLC, and Transseptal Solutions, Inc.

Persistence Market Research has also mentioned the developments in the transseptal access systems market. For instance – Acutus Medical, in December 2020, did receive European approval and CE Mark for its AcQCross Transseptal System. It comes across as a 100% integrated family of transseptal crossing products for rendering efficiency and safety in any of the procedures that need left heart access. The same Acutus, in May 2019, completed acquisition of Rhythm Xience Inc. for adding therapy, access, rhythm monitoring solutions and diagnostics to its portfolio.

The transseptal access systems market will take a persistent turn in the upcoming period – Persistence Market Research

To Top

Pin It on Pinterest

Share This